Abstract
High serum copper (s-Cu) has been reported as an independent risk factor for cardiovascular disease (CVD) in both case-control (1) and large prospective population studies (2, 3). The mechanisms underlying these associations are largely unclear. In vitro Cu is highly efficient in promoting the oxidation of low-density-lipoprotein (4), which is considered an important step in atherogenesis. A synergistic effect between the pro-oxidant action of Cu and low status of selenium (an antioxidant), leading to atherogenesis via an imbalance of defence against free radicals has been suggested in vivo (5). Also, experimental animal studies suggest a role of Cu in lipid metabolism, particularly in cholesterol (6) and fatty acid metabolism (7). Within the framework of a cross-sectional survey aimed to study the status of several trace elements in a sample of healthy adults (8), we examined the relationships between s-Cu and several, well-known, risk factors for CVD, including plasma lipoproteins and fatty acids, and coagulation factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.M. Singh, R. Singh, A. Khare, et al., Angiology 36, 504–510 (1985).
F.J. Kok, CM. Van Duijn, A. Hofman, et al., Am. J. Epidemiol. 128, 352–359 (1988).
J.T. Salonen, R. Salonen, H. Korpela, S. Suntioinen and J. Tuomiletho, Am. J. Epidemiol. 134, 268–276 (1991).
H. Esterbauer, J. Gebicki, H. Puhl and J. Jürgens, Free Rad. Biol. Med 13, 341–390 (1992).
J.T. Salonen, R. Salonen, K. Seppänen, M. Kantola, S. Suntioinen and H. Korpela, Br Med. J. 302, 756–760 (1991).
N.Y. Yount, D.J. McNamara, A.A. Al-Othman and K.Y. Lei, J. Nutr. Biochem. 1, 27–33 (1990).
S.C. Cunnane, Prog. Lipid. Res. 21, 73–90 (1982).
O. Olivieri, A.M. Stanzial, D. Girelli, et al., Am. J. Clin. Nutr. 60, 510–517 (1994).
B. Welz, Atomic absorption spectrometry, 2nd ed., VCH Publishers, Weinheim, (1985).
D.F. Horrobin, Semin. Thromb. Haemostasis, 19, 129–137 (1993).
D. Steinberg; N. Engl. J. Med. 328, 1487–1489 (1993).
R.J. Shamberger, in Biochemistry of the essential ultratrace elements, E. Frieden, ed., Plenum Press, New York pp. 201–237(1984).
P.E. Johnson and D.B. Milne, Am. J. Clin. Nutr. 56, 917–925 (1992).
N.W. Solomons, Am. J. Clin. Nutr. 32, 856–871 (1979).
N.S. Cook and D. Ubben, Trends Pharmacol. Sci, 11, 444–451 (1990).
E. Ernst and K.L. Resch, Ann. Intern. Med. 118, 956–963 (1993).
R. Rosse, Nature 362, 801–809 (1993).
R.A. Di Silvestro, Nutr. Res. 10, 355–358 (1990).
W.R. Church, R.L. Jernigan, J. Toole, et al., Proc. Natl. Acad. Sci. USA 81, 6934–6937 (1984).
K.G. Mann, CM. Lawler, G.A. Vehar, W.R. Church, J. Biol. Chem. 21, 12949–12951 (1984).
S.M. Lynch, L.M. Klevay, J. Nutr. Biochem. 3, 387–391 (1992).
S.M. Lynch, L.M. Klevay, Nutr. Res. 13, 913–922 (1993).
G. Marx, M. Chevion, Thromb. Res. 40, 11–18(1985).
S.E. Lind, J.R. McDonagh and C.J. Smith, Blood 82, 1522–1531 (1993).
T.W. Meade, S. Mellows, M. Brozovic, et al., Lancet ii, 533–537 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Girelli, D. et al. (1996). Relationships between Serum Copper Concentration and Cardiovascular Risk Factors in Normal Subjects. In: Nève, J., Chappuis, P., Lamand, M. (eds) Therapeutic Uses of Trace Elements. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0167-5_67
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0167-5_67
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0169-9
Online ISBN: 978-1-4899-0167-5
eBook Packages: Springer Book Archive